Rapport Therapeutics (RAPP) Other Gross PP&E Adjustments (2023 - 2026)
Rapport Therapeutics (RAPP) has 4 years of Other Gross PP&E Adjustments data on record, last reported at -$6.3 million in Q1 2026.
- On a quarterly basis, Other Gross PP&E Adjustments fell 77.88% to -$6.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$6.3 million, a 77.88% decrease, with the full-year FY2025 number at -$6.2 million, down 408.54% from a year prior.
- Other Gross PP&E Adjustments reached -$6.3 million in Q1 2026 per RAPP's latest filing, down from -$6.2 million in the prior quarter.
- Over the last five years, Other Gross PP&E Adjustments for RAPP hit a ceiling of $2.2 million in Q3 2024 and a floor of -$7.2 million in Q2 2025.
- A 4-year average of -$2.9 million and a median of -$3.6 million in 2025 define the central range for Other Gross PP&E Adjustments.
- Peak YoY movement for Other Gross PP&E Adjustments: soared 285.12% in 2024, then tumbled 1351.48% in 2025.
- Tracing RAPP's Other Gross PP&E Adjustments over 4 years: stood at -$1.1 million in 2023, then skyrocketed by 285.12% to $2.0 million in 2024, then tumbled by 408.54% to -$6.2 million in 2025, then decreased by 2.67% to -$6.3 million in 2026.
- Business Quant data shows Other Gross PP&E Adjustments for RAPP at -$6.3 million in Q1 2026, -$6.2 million in Q4 2025, and -$6.9 million in Q3 2025.